Navigating AI-assisted inventions and copyright in a multi-jurisdictional landscape With AI-driven discoveries reshaping the life sciences industry, intellectual property laws worldwide are evolving. This session will explore the latest guidance from the USPTO and the US Copyright Office on AI-assisted inventorship and authorship, alongside parallel developments in the European Patent Office (EPO), China, and other major IP jurisdictions. Experts will discuss how different regions are interpreting human inventorship, the risks of AI-generated data in drug development, and global best practices for securing AI-driven innovations in the life sciences sector